A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)
A phase 2 trial of Zenocutuzumab in non-small-cell lung cancer and pancreatic ductal adenocarcinoma, run by Partner Therapeutics, Inc., active and no longer recruiting.
Overview
A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy) is a phase 2 interventional study registered as NCT02912949 by Partner Therapeutics, Inc., with 250 participants enrolled, started 2015-01 and due to reach its primary completion in 2026-12-31. Interventions recorded: zenocutuzumab (MCLA-128).
Similar pages
not linked directly; found by shared links- TrialPhase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag pipeline.
- TrialA Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag pipeline.
- TrialA Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag pipeline.
- TrialA Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag pipeline.
- TrialStudy to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag pipeline.
- TrialStudy of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag pipeline.
- TrialSL-28 for Advanced Solid Tumours
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag pipeline.
- TrialA Study of MT-4561 in Patients With Various Advanced Solid Tumors
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag pipeline.